Cargando…
Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians
Background: The diagnosis of Alzheimer's disease (AD) can bring financial and emotional consequences to patients and caregivers. Whether or not the diagnosis should be disclosed to patients is a matter of debate amongst physicians and can be influenced by culture and experience. Objective: To...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Revinter Publicações Ltda.
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631852/ https://www.ncbi.nlm.nih.gov/pubmed/37939720 http://dx.doi.org/10.1055/s-0043-1776316 |
_version_ | 1785146102472769536 |
---|---|
author | Souza, Vitor Santos de Guazzelli, Sofia Brunchport Cruz, Leonardo Cardoso Resende, Elisa de Paula França Souza, Leonardo Cruz de Barbosa, Maira Tonidandel Caramelli, Paulo |
author_facet | Souza, Vitor Santos de Guazzelli, Sofia Brunchport Cruz, Leonardo Cardoso Resende, Elisa de Paula França Souza, Leonardo Cruz de Barbosa, Maira Tonidandel Caramelli, Paulo |
author_sort | Souza, Vitor Santos de |
collection | PubMed |
description | Background: The diagnosis of Alzheimer's disease (AD) can bring financial and emotional consequences to patients and caregivers. Whether or not the diagnosis should be disclosed to patients is a matter of debate amongst physicians and can be influenced by culture and experience. Objective: To investigate the current practice of physicians who attend and treat patients with dementia in Brazil regarding the disclosure of dementia diagnosis and compare the practice with what has been performed 15 years ago in the country. Methods: Data were evaluated using an electronic questionnaire. The questions used to carry out this research were similar to the questions of the study carried out 15 years ago 9. The form was sent to the Brazilian Academy of Neurology, the Brazilian Association of Geriatrics and Gerontology, and the Brazilian Association of Psychiatry, which forwarded it to their members. Analyses were conducted through non-parametric statistical tests, with a post-hoc assessment. Results: 397 physicians responded to the survey, of which 231 are neurologists, 124 geriatricians, 29 psychiatrists and 13 from other specialties. The mean age was 45.2 years. The majority (66.7%) of the physicians reveal the diagnosis of AD always or usually. The youngest group of neurologists were more likely to disclose the diagnosis than the oldest group with a significant difference between them. In comparison to the 2008 Brazilian study, the percentage of physicians who always or usually disclose the diagnosis has risen by 22%. On the other hand, 12.3% of the physicians rarely or never disclose the diagnosis, in comparison to 25,3% in 2008. The main reasons for not disclosing the diagnosis concern the patients' mental health. Conclusion: Advances in dementia knowledge and biomarkers availability probably explain the increase in the rate of disclosure. The main challenge is to reconcile the autonomy of affected individuals, mental health issues after the diagnosis and the family member's opinion. |
format | Online Article Text |
id | pubmed-10631852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Thieme Revinter Publicações Ltda. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106318522023-11-15 Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians Souza, Vitor Santos de Guazzelli, Sofia Brunchport Cruz, Leonardo Cardoso Resende, Elisa de Paula França Souza, Leonardo Cruz de Barbosa, Maira Tonidandel Caramelli, Paulo Arq Neuropsiquiatr Background: The diagnosis of Alzheimer's disease (AD) can bring financial and emotional consequences to patients and caregivers. Whether or not the diagnosis should be disclosed to patients is a matter of debate amongst physicians and can be influenced by culture and experience. Objective: To investigate the current practice of physicians who attend and treat patients with dementia in Brazil regarding the disclosure of dementia diagnosis and compare the practice with what has been performed 15 years ago in the country. Methods: Data were evaluated using an electronic questionnaire. The questions used to carry out this research were similar to the questions of the study carried out 15 years ago 9. The form was sent to the Brazilian Academy of Neurology, the Brazilian Association of Geriatrics and Gerontology, and the Brazilian Association of Psychiatry, which forwarded it to their members. Analyses were conducted through non-parametric statistical tests, with a post-hoc assessment. Results: 397 physicians responded to the survey, of which 231 are neurologists, 124 geriatricians, 29 psychiatrists and 13 from other specialties. The mean age was 45.2 years. The majority (66.7%) of the physicians reveal the diagnosis of AD always or usually. The youngest group of neurologists were more likely to disclose the diagnosis than the oldest group with a significant difference between them. In comparison to the 2008 Brazilian study, the percentage of physicians who always or usually disclose the diagnosis has risen by 22%. On the other hand, 12.3% of the physicians rarely or never disclose the diagnosis, in comparison to 25,3% in 2008. The main reasons for not disclosing the diagnosis concern the patients' mental health. Conclusion: Advances in dementia knowledge and biomarkers availability probably explain the increase in the rate of disclosure. The main challenge is to reconcile the autonomy of affected individuals, mental health issues after the diagnosis and the family member's opinion. Thieme Revinter Publicações Ltda. 2023-11-08 /pmc/articles/PMC10631852/ /pubmed/37939720 http://dx.doi.org/10.1055/s-0043-1776316 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Souza, Vitor Santos de Guazzelli, Sofia Brunchport Cruz, Leonardo Cardoso Resende, Elisa de Paula França Souza, Leonardo Cruz de Barbosa, Maira Tonidandel Caramelli, Paulo Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians |
title | Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians |
title_full | Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians |
title_fullStr | Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians |
title_full_unstemmed | Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians |
title_short | Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians |
title_sort | diagnostic disclosure of alzheimer's disease in brazil: a national survey of specialized physicians |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631852/ https://www.ncbi.nlm.nih.gov/pubmed/37939720 http://dx.doi.org/10.1055/s-0043-1776316 |
work_keys_str_mv | AT souzavitorsantosde diagnosticdisclosureofalzheimersdiseaseinbrazilanationalsurveyofspecializedphysicians AT guazzellisofiabrunchport diagnosticdisclosureofalzheimersdiseaseinbrazilanationalsurveyofspecializedphysicians AT cruzleonardocardoso diagnosticdisclosureofalzheimersdiseaseinbrazilanationalsurveyofspecializedphysicians AT resendeelisadepaulafranca diagnosticdisclosureofalzheimersdiseaseinbrazilanationalsurveyofspecializedphysicians AT souzaleonardocruzde diagnosticdisclosureofalzheimersdiseaseinbrazilanationalsurveyofspecializedphysicians AT barbosamairatonidandel diagnosticdisclosureofalzheimersdiseaseinbrazilanationalsurveyofspecializedphysicians AT caramellipaulo diagnosticdisclosureofalzheimersdiseaseinbrazilanationalsurveyofspecializedphysicians |